Final Study Report of Andexanet Alfa for Major Bleeding With Factor Xa Inhibitors
Truman J. Milling(Population Health Research Institute), Rainer Dziewas(Klinikum Osnabrück), Michiel Coppens(Pulmonary Hypertension Association), Alexander T. Cohen(King's College London), Jan Beyer‐Westendorf(Technische Universität Dresden), C. Michael Gibson(Baim Institute for Clinical Research), Joanna Y. Wilson(Unknown), Andrew M. Demchuk(University of Calgary), Daniel J. Pallin(Brigham and Women's Hospital), Carol L. Clark(Beaumont Hospital, Royal Oak), Neha Patel(Cleveland Clinic), Aveh Bastani, Michael Spohn(Centre Hospitalier Universitaire de Clermont-Ferrand), Ashkan Shoamanesh(Population Health Research Institute), Ravinder Anand(Population Health Research Institute), Franck Verschuren(UCLouvain), Joshua N. Goldstein(Massachusetts General Hospital), James Welker(Population Health Research Institute), Jeannot Schmidt(Centre National de la Recherche Scientifique), Mauricio Concha(Population Health Research Institute), Arvind Venkat, Peter Verhamme(KU Leuven), William C. Shillinglaw(McMaster University), Alvin H. Schmaier(Case Western Reserve University), Majed A. Refaai(Centre Hospitalier Universitaire de Clermont-Ferrand), Bruce Koch(Alexion Pharma (Switzerland)), Gary Braun(Harvard University), Gregory J. Fermann(Harvard University), Katharina Althaus(Christophorus Kliniken), Stuart J. Connolly(Population Health Research Institute), Mark Crowther(Population Health Research Institute), Ian J. Welsby(Durham VA Health Care System), John W. Eikelboom(Population Health Research Institute), José López‐Sendón(Hospital Universitario La Paz), James Fulmer(Morphotek (United States)), Lizhen Xu(Hospital for Sick Children), Pierre Albaladejo(Population Health Research Institute), Keith Dombrowski, L. Van Keer(Population Health Research Institute), M. Rehman(Centre Hospitalier Universitaire de Clermont-Ferrand), Mark Blostein(Jewish General Hospital), T. Doeppner(Population Health Research Institute), D.J. Kereiakes(Université Pierre Mendès France), John A. Cornell(Hesperia Hospital), Jörg Berrouschot(Klinikum Altenburger Land), Saskia Middeldorp(Radboud University Nijmegen), E. Schwarz(Université Pierre Mendès France), Tohru Takata(New York University)
Cited by 153
Related Papers
Dabigatran versus Warfarin in Patients with Atrial Fibrillation
|New England Journal of Medicine|2009|11.2k
Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials
|The Lancet|2016|7.6k
Prasugrel versus Clopidogrel in Patients with Acute Coronary Syndromes
|New England Journal of Medicine|2007|6.7k
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up
|Journal of the American College of Cardiology|2020|2.9k